We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

84 hedge funds and large institutions have $381M invested in Editas Medicine in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 23 increasing their positions, 18 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

290% more call options, than puts

Call options by funds: $335K | Put options by funds: $86K

100% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 10

64.09% more ownership

Funds ownership: 0% → 64.09% (+64%)

28% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 18

27% more capital invested

Capital invested by funds: $300M → $381M (+$81M)

12% more funds holding

Funds holding: 75 → 84 (+9)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
84
Holders Change
+9
Holders Change %
+12%
% of All Funds
2.1%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.1%
New
20
Increased
23
Reduced
18
Closed
10
Calls
$335K
Puts
$86K
Net Calls
+$249K
Net Calls Change
+$325K

Top Buyers

1
EC
EcoR1 Capital
California
+$9.51M
2
BFA
BlackRock Fund Advisors
California
+$8.13M
3
FCMI
Foresite Capital Management III
California
+$4.17M
4
CS
Credit Suisse
Switzerland
+$2.14M
5
Norges Bank
Norges Bank
Norway
+$1.38M

Top Sellers

1
PVMCV
Polaris Venture Management Co VI
Massachusetts
-$5.45M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$3.69M
3
Renaissance Technologies
Renaissance Technologies
New York
-$1.73M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$1.17M
5
Deutsche Bank
Deutsche Bank
Germany
-$847K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$89.2M +$95.3K +6,278 +0.1%
PVMCV
2
Polaris Venture Management Co VI
Massachusetts
$61.6M -$5.45M -359,027 -9%
FP
3
Flagship Pioneering
Massachusetts
$56.1M – – –
DM
4
Deerfield Management
New York
$27.7M – – –
Viking Global Investors
5
Viking Global Investors
Connecticut
$27.7M – – –
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$26.5M -$3.69M -242,862 -13%
Vanguard Group
7
Vanguard Group
Pennsylvania
$21.4M +$1.01M +66,825 +5%
BFA
8
BlackRock Fund Advisors
California
$11.6M +$8.13M +535,677 +302%
EC
9
EcoR1 Capital
California
$10.2M +$9.51M +626,762 New
Capital World Investors
10
Capital World Investors
California
$4.79M – – –
FCMI
11
Foresite Capital Management III
California
$4.46M +$4.17M +274,910 New
BIT
12
BlackRock Institutional Trust
California
$4.23M +$1.36M +89,900 +53%
CS
13
Credit Suisse
Switzerland
$3.67M +$2.14M +140,849 +165%
Morgan Stanley
14
Morgan Stanley
New York
$3.38M -$668K -44,027 -17%
SM
15
Sabby Management
Florida
$1.87M -$304K -20,000 -15%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$1.85M +$172K +11,335 +11%
State Street
17
State Street
Massachusetts
$1.71M +$37.6K +2,476 +2%
Balyasny Asset Management
18
Balyasny Asset Management
Illinois
$1.54M +$528K +34,800 +58%
Norges Bank
19
Norges Bank
Norway
$1.48M +$1.38M +91,102 New
HCMT
20
Highland Capital Management (Texas)
Texas
$1.46M +$1.37M +90,000 New
Northern Trust
21
Northern Trust
Illinois
$1.45M +$18K +1,187 +1%
CGL
22
Clarius Group LLC
Washington
$1.42M – – –
OFM
23
Omega Fund Management
Massachusetts
$1.07M – – –
CC
24
Casdin Capital
New York
$1.05M -$311K -20,470 -24%
CCP
25
Clough Capital Partners
Massachusetts
$818K +$765K +50,400 New
1
2 3 4

EDIT Hedge Fund Activity: Q4 2016 in Review

84 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q4 2016, worth a combined $381M — up 27% from $300M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new EDIT positions and 10 closed out — a net gain of 10 holders — while 23 added to existing stakes and 18 trimmed.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $9.51M. The largest seller was Polaris Venture Management Co VI, cutting an estimated $5.45M.

  • 84 institutional investors held Editas Medicine (EDIT) as of Q4 2016, up from 75 in Q3 2016.
  • Funds reported $381M of Editas Medicine stock for Q4 2016, up 27% quarter-over-quarter.
  • 20 funds opened new Editas Medicine positions in Q4 2016 and 10 closed out, a net change of +10 holders.
  • The largest Editas Medicine buyer in Q4 2016 was EcoR1 Capital, an estimated $9.51M added.
  • The largest Editas Medicine seller in Q4 2016 was Polaris Venture Management Co VI, an estimated $5.45M sold.

Based on aggregated 13F filings for Q4 2016.